ABSTRACT
Pancreatic Lipase (PL) is the most important enzyme in digestion of triglycerides. One of the strategies in prevention or treatment of obesity is altering metabolism of lipids by inhibition of dietary fat absorption. One hundred plant extracts were prepared and botanically identified. The air dried plants were extracted with methanol. Anti lipase activity of each plant was determined by turbidimetric assay. Quercus infectoria, Eucalyptus galbie, Rosa damascena and Levisticum officinale showed more than 50% inhibition on the enzyme activity. Kinetic study of the enzyme was performed in the presence of effective extracts. Levisticum officinale showed mixed inhibition and Rosa damascena, Quercus infectoria and Eucalyptus galbie showed non-competitive inhibition by double-reciprocal Lineweaver-Burk plot analysis. Under the controlled condition, Km value for enzyme was 0.3 mM and Vmax was 0.078 mM min-1; Vmax in the presence of Quercus infectoria, Eucalyptus galbie, Rosa damascena and Levisticum officinale extracts were 0.051, 0.056, 0.049 and 0.068 mM min-1, respectively. Because of mixed inhibition, Levisticum officinale showed a different Km value of 0.617 mM. Further studies needed to elucidate the effectiveness of these active extracts in vivo and attempt should be made to purify their active components to be used as safer and cheaper therapeutic agents in future.
PDF Abstract XML References Citation
How to cite this article
DOI: 10.3923/ijp.2010.18.24
URL: https://scialert.net/abstract/?doi=ijp.2010.18.24
INTRODUCTION
Plants are one of the most important sources of drugs and their medicinal use has a long history. Literature review indicate that therapeutic use of plants goes back to 4000-5000 B.C. (Prakash and Gupta, 2005). Plants also play a principal role in the introduction of new therapeutic agents (Xie et al., 2007; Kumar et al., 2008). Obesity in addition to be a health problem is a social problem and the number of people suffering from this disease are increasing rapidly in the world and it has become the center of much attention by public and especially health-related institutions, whose aim is to reduce its prevalence (Moro and Basile, 2000; Han et al., 2007). There are more than 1 billion overweight adults that among them at least 300 million are clinically obese (Birari and Bhutani, 2007). The effect of dietary fat on hyperlipidaemia is well known as it is associated with various diseases like obesity, diabetes, hypertension, cardiovascular problems, metabolic syndrome and cancer (Moreno et al., 2003; Sharma et al., 2005; Han et al., 2007). Digestion of dietary triglycerides, which represent 90-95% of the total ingested fat, is driven to completion in the intestine by pancreatic lipase, in conjunction with pancreatic co-lipase and bile that accelerate triglyceride absorption from the small intestine to the enterocytes. If somehow this initial movement of triglycerides from the intestinal lumen be blocked, hyperlipidaemia can be prevented (Ros, 2000; Sebban-Kreuzer et al., 2003; Sharma et al., 2005; Moreno et al., 2006).
The most common anti-obesity drug is Orlistat, a hydrogenated derivative of lipstatin derived from Streptomyces toxitricini, a potent inhibitor of gastric, pancreatic and carboxyl ester lipase and it has been proved to be effective for the treatment of human obesity by 35 percent reduction in fat absorption (Moreno et al., 2003; Sebban-Kreuzer et al., 2003; Sharma et al., 2005). Management of hyperlipidaemia without any side effect is still a challenge to the medical system (Xie et al., 2007). For instance, consumption of synthetic drugs leads to hyperuricemia, diarrhea, nausea, nyositis, gastric irritation, flushing, dry skin, oily spotting, flatus with discharge, fecal incontinence and abnormal liver function (Greenway, 1999; Kumar et al., 2008). While, plant products are considered to have less toxic and side effects than synthetic ones (Xie et al., 2007; Kumar et al., 2008). The existence of lipase inhibitors has been demonstrated in different plant species including Marine algae, soy bean, wheat, teasaponin, Cassia mimosoides, Camelia sinensis, Platycodon grandiflorum, Ambrosia artemisiaefolia, Calluna vulgaris, Citrus limon, Platycodin D, Dioscorea nipponica, Salacia reticulate, Salix matsudara, Licochalcone A from Glycyrrhiza uralensis, Grape seed extract and Scabiosa tschiliensis (Han et al., 2001; Zhao and Kim, 2004; Sharma et al., 2005; Moreno et al., 2006; Huerta et al., 2007; Won et al., 2007). However, more searches for finding more effective lipase inhibitors from natural sources are needed. In the present study, we have screened methanol extracts of various plants for their anti-lipase activity to find safer and cheaper medicines in prevention and control of hyperlipidaemia related diseases.
MATERIALS AND METHODS
Plants: Flowers, aerial parts, fruits, roots and seeds of different plants were collected from various provinces of Iran or purchased from the medicinal herbal markets in Kerman city. Scientific names of the plants were authenticated by Dr. Mirtajaldini, Department of Botany, Bahonar University and Kerman, Iran (Table 1). A voucher specimen from each plant was deposited at the herbarium of the Herbal Medicines Research Center, Faculty of Pharmacy and Kerman University of Medical Sciences, Iran. Each plant material was air dried and grounded into fine powder. The powdered material (20 g) was extracted with 200 mL of absolute methanol for 24 h. The suspensions were filtered and air-dried; these air-dried samples were stored at -20°C until use (Sharma et al., 2005). Solution of 5 mg mL-1 of each extracts in 0.05 M phosphate buffer was prepared just before enzyme assay.
Enzyme assay: Pancreatic lipase activity was measured by turbidimetric method, used by Vogel and Zieve (Shihabi and Bishop, 1971; Burtis et al., 2006). The assay was based on the reduction in turbidity of a triolein emulsion by porcine pancreatic lipase (5 unit, Sigma, USA) at 340 nm, pH 8.9 and 37°C (Carrere et al., 1987; Han et al., 2001; Yamada and Fujita, 2007). Ten microliter of each preparations containing 50 μg crude extract was added to the reaction mixture including; Triolein (0.3 mmol L-1), sodium deoxycholate (16.7 mmol L-1), colipase (4 mg L-1), calcium chloride (0.04 mmol L-1) and 0.05 M tris buffer (final volume of 1 mL). The mixture was incubated at 37°C for 15 min and absorbance at 340 nm was determined spectrophotometrically (Han et al., 2001; Yamada and Fujita, 2007). Triolein was solubilized in 0.2% Triton X100 (Rocha et al., 1999; Tashiro et al., 1992). The active extracts re-examined by commercial lipase assay kit (Randox, Laboratories. LTD. UK).
Pancreatic lipase inhibitory activity was calculated according to the following formula (Huerta et al., 2007):
Table 1: | Anti porcine pancreatic lipase activity of plants extracts |
![]() | |
![]() | |
The enzyme activity was measured by turbidimetric assay. Reaction mixture was contained triolein as the substrate, sodium deoxycholate, colipase, calcium chloride and tris buffer. Reduction in turbidity was assayed in 340 nm |
Inhibition (%) = [AControl-AExtract/AControl]x100
Kinetic study: In order to measure the inhibition mode by mathanolic extract of Quercus infectoria, Eucalyptus galbie, Rosa damascena and Levisticum officinale, pancreatic lipase activity was assayed with increasing concentrations of triolein as substrate (0.15, 0.3, 0.625 and 1.25 mM) in the absence and presence of two different concentrations of the extracts (0.05 and 0.15 mg mL-1). Inhibition mode was determined by double-reciprocal Lineweaver-Burk plot analysis of the data resulted from enzyme assays containing various concentrations of triolein and extracts according to the Michaelis-Menten kinetics (Zhao and Kim, 2004; Won et al., 2007).
![]() | |
Fig. 1: | The Lineweaver-Burk plot of kinetic analysis for porcine pancreatic lipase at two different concentrations of Quercus infectoria (0.05 and 0.15 mg mL-1) in the presence of four different triolein concentrations |
RESULTS
Plants with Pancreatic lipase inhibitory effect: Among one hundred extracts; Quercus infectoria, Eucalyptus galbie, Rosa damascena and Levisticum officinale showed 85, 64, 57 and 55% inhibitory effect on pancreatic lipase, respectively.
Extracts prepared from Pistacia vera, Myrtus communis, Otostegia persica, Urtica urens, Cinnamomum zeylanicum, Rheum ribes, Pimpinella anisum, Alhagi camelorum, Nigella sativa, Carthamus oxyacantha, Arctium lappa, Trigonella foenum graecum, Ficus carica and Buninm persicum showed an inhibitory effect between 25-50% on pancreatic lipase. The rest of plant extracts showed less than 25% or no inhibition on the activity of the enzyme in this study (Table 1).
Kinetic analysis of porcine pancreatic lipase inhibition: The inhibition mode of the four most active plant extracts was analyzed by double-reciprocal Lineweaver-Burk plot. The enzyme kinetics demonstrated non-competitive inhibition on porcine pancreatic lipase activity by Quercus infectoria (Fig. 1); Eucalyptus galbie (Fig. 2) and Rosa damascene (Fig. 3) and mixed inhibition by Levisticum officinale (Fig. 4). The Km value of triolein for porcine pancreatic lipase was 0.3 mM and Vmax value was 0.078 mM min-1. The Vmax values of the enzyme in the presence of Quercus infectoria (Table 2), Eucalyptus galbie (Table 3), Rosa damascene (Table 4) and Levisticum officinale (Table 5) extracts were 0.051, 0.056, 0.049 and 0.068 mM min-1, respectively. The Ki value of 0.341, 0.383, 0.335 and 0.930 mg mL-1 was found for Quercus infectoria, Eucalyptus galbie, Rosa damascena and Levisticum officinale, respectively.
Table 2: | Kinetics analysis of porcine pancreatic lipase under different concentrations of triolein and Quercus infectoria extract |
![]() | |
The enzyme activity was measured by turbidimetric assay. Reaction mixture contained of triolein, deoxycholate, colipase, calcium chloride and tris buffer. Turbidity determined by measuring the absorbance at 340 nm |
Table 3: | Kinetics analysis of porcine pancreatic lipase under different concentrations of triolein and Eucalyptus galbie extract |
![]() | |
The enzyme activity was measured by turbidimetric assay. Reaction mixture contained of triolein, deoxycholate, colipase, calcium chloride and tris buffer. Turbidity determined by measuring the absorbance at 340 nm |
Table 4: | Kinetics analysis of porcine pancreatic lipase under different concentrations of triolein and Rosa damascena extract |
![]() | |
The enzyme activity was measured by lipaturbidimetric assay. Reaction mixture contained of triolein, deoxycholate, colipase, calcium chloride and tris buffer. Turbidity determined by measuring the absorbance at 340 nm |
Table 5: | Kinetics analysis of porcine pancreatic lipase under different concentrations of triolein and Levisticum officinale extract |
![]() | |
The enzyme activity was measured by turbidimetric assay. Reaction mixture contained of triolein, deoxycholate, colipase, calcium chloride and tris buffer. Turbidity determined by measuring the absorbance at 340 nm |
![]() | |
Fig. 2: | The Lineweaver-Burk plot of kinetic analysis for porcine pancreatic lipase at two different concentrations of Eucalyptus galbie (0.05 and 0.15 mg mL-1) in the presence of four different triolein concentrations |
![]() | |
Fig. 3: | The Lineweaver-Burk plot of kinetic analysis for porcine pancreatic lipase at two different concentrations of Rosa damascena (0.05 and 0.15 mg mL-1) in the presence of four different triolein concentrations |
![]() | |
Fig. 4: | The Lineweaver-Burk plot of kinetic analysis for porcine pancreatic lipase at two different concentrations of Levisticum officinale (0.05 and 0.15 mg mL-1) in the presence of four different triolein concentrations |
DISCUSSION
Obesity is becoming one of the biggest complications to global health in this millennium (Birari and Bhutani, 2007). Pancreatic lipase is the key enzyme for lipid absorption that hydrolysis triacylglycerols in the gastrointestinal tract (Jang et al., 2008). Pancreatic lipase inhibitors which help to limit intestinal fat absorbtion at the initial stage, have been proved as useful medications for the treatment of hyperlipidaemia and a great promise as anti-obesity agents (Sharma et al., 2005). Presence of pancreatic lipase inhibitors has been reported in some natural resources (Han et al., 2001; Zhao and Kim, 2004; Sharma et al., 2005; Moreno et al., 2006; Huerta et al., 2007; Won et al., 2007) but due to the problem arisen by these extracts, further investigations for finding new and better pancreatic lipase inhibitors in the nature is a necessity. In this study we demonstrated that galls of Quercus infectoria, leaves of Eucalyptus galbie, flowers of Rosa damascene and roots of Levisticum officinale have strong anti porcine pancreatic lipase activity. We determined their kinetics properties that have not done so far. The most common anti obesity drug available in the market is Orlistate, which was shown to be irreversible inhibitor of pancreatic lipase (Greenway, 1999; Sharma et al., 2005). Platycodin D and tea-saponin have inhibited the pancreatic lipase activity in a competitive manner which is in contrast to our results suggesting a non-competitive or mixed inhibition of pancreatic lipase by our extracts (Han et al., 2001; Zhao and Kim, 2004). However, in accordance with our results, some studies reported non-competitive inhibition of pancreatic lipase (Won et al., 2007; Huerta et al., 2007). A mixed-inhibitor binds at a distinct site from the active site but it can binds to the enzyme or enzyme-substrate complex as well. It will affect Km and Vmax of the reaction. Components of Levisticum officinale, extract which showed mixed type of inhibition (Table 5), can bind to the enzyme or Enzyme-Substrate (ES) complex and block its activity. When inhibitor bind to the enzyme and/or ES complex it defined as non-competitive inhibition which inhibitor affects only on the Vmax of the reaction but has no effect on complex formation between the enzyme and the substrates (Nelson and Cox, 2005). Therefore, the three extracts which showed non-competitive inhibition on PL activity, probably have components that bind to E or ES complex (Table 2-4). It had been shown that, Crocin a glycosylated carotenoid, is the major active constituents of Gardenia jasminoids. This compound exhibited potent hypo-triglyceridemic activity. Crocin competitively and reversibly inhibited PL and Crocin's metabolite, crocetin, also potently inhibited PL. Crocin and crocetin also showed potent hypolipidemic activity in Triton WR-133 or corn oil induced hyper-lipidemic mice. Another compound, Dioscin isolated from methanol extract of Dioscorea nipponica was shown to inhibit PL (Birari and Bhutani, 2007). Similar inhibitors might be responsible for anti lipase activities in our study. The active constituents of these plants have not been completely known and further investigation needed to be done.
Afromomum meleguetta is an African plant which its extract has shown the most potent inhibitor of PL (Ekanem et al., 2007). The methanol extract from the pericarps of Sapindus rarak was found to have pancreatic lipase inhibitory activity (Morikawa et al., 2009). Pribitkin and Boger (2001) asserted that Zingiber officinale inhibits platelets function and Apium graveolens, Foeniculum vulgare, Levisticum officinale and Ficus carica have photosensitizing effect. Here we showed the anti PL activity of these plants (Table 1). Jang et al. (2008) isolated a new pancreatic inhibitor from roots of Actinidia arguta. Slanc et al. (2009) showed that Crocus sativa did not show any inhibition on PL and Menha piperita showed below 40% inhibition on activity of PL. This is in contrast with our results. Also, they asserted that Pimpinella anisum, Arctium lappa, Origanum majorana, Althaea officinalis, Ficus carica, Citrus sinensis and Urtica dioica showed PL inhibitory activity below 40% that are along with our results. Arctium lappa and Linum usitatissimum showed slight PL inhibition in our study while Peter et al. (2009) showed that Arctium lappa and Linum usitatissimum have strong inhibitory effect on PL.
The galls of Quercus infectoria and flowers of Rosa damascenea had shown non-competitive inhibitory effect on Alpha mannosidase activity (Gholamhoseinian et al., 2008a). Quercus infectoria, Rosa damascena and Levisticum officinale showed anti Alpha glucosidase activity, a target enzyme with therapeutic potential in the treatment of diabetes, metastasic cancer and lysosomal storage disease and also showed antiviral effects against human immunodeficiency virus and hepatitis C virus infection (Matsui et al., 2004; Chapel et al., 2006; Gholamhoseinian et al., 2008b). Galls of Quercus infectoria possess many therapeutic activities such as antidiabetic, anti-parkinsonian, anti-tremorine, anti-inflammatory, antiviral, anti- microbial, antifungal and larvicidal activity (Kaur et al., 2004; Basri and Fan, 2005) and showed high potential in skin whitening and antioxidant properties (Pin et al., 2006). We showed that Eucalyptus galbie is one of the porcine pancreatic lipase inhibitors. It had shown that Eucalyptus galbie is an effective agent in reducing the growth of fungus and also has anti diabetic activity (Grover et al., 2002; Joseph et al., 2008). These plants could represent active source of new anti-lipase activity. Further in vivo study on animal model must be done in order to confirm these results. These four plants will be examined in order to isolate, identify and characterize the active ingredients to establish the nature of their lipid lowering activity. This study may serve as a foundation for comprehensive and safe therapeutic strategies to the management of obesity and other related diseases.
ACKNOWLEDGMENT
This study was supported by the research funds provided by the Vice Chancellor for Research and the Kerman Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
REFERENCES
- Basri, D.F. and S.H. Fan, 2005. The potential of aqueous and acetone extracts of galls of Quercus infectoria as antibacterial agents. Indian J. Pharmacol., 37: 26-29.
CrossRefDirect Link - Birari, R.B. and K.K. Bhutani, 2007. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discovery Today, 12: 879-889.
CrossRef - Carrere, J., G. Serre and C. Vincent, 1987. Human serum pancreatic lipase and trypsin 1 in aging: Enzymatic and immunoenzymatic assays. J. Gerontol., 42: 315-317.
CrossRefDirect Link - Chapel, C., C. Garcia, P. Roingeard, N. Zitzmann and J. Dubuisson et al., 2006. Antiviral effect of α-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles. J. General Virol., 87: 861-871.
Direct Link - Ekanem, A.P., M. Wang, J.E. Simon and D.A. Moreno, 2007. Antiobesity properties of two African plants (Afromomum meleguetta and Spilanthes acmella) by pancreatic lipase inhibition. Phytother. Res., 21: 1253-1255.
Direct Link - Gholamhoseinian, A., H. Fallah, F. Sharifi-Far and M. Mirtajaddini, 2008. Alpha mannosidase inhibitory effect of some Iranian plant extracts. Int. J. Pharmacol., 4: 460-465.
CrossRefDirect Link - Gholamhoseinian, A., H. Fallah, F. Sharifi-far and M. Mirtajaddini, 2008. The inhibitory effect of some iranian plants extracts on the alpha glucosidase. Iran. J. Basic Med. Sci., 11: 1-9.
Direct Link - Greenway, F., 1999. Obesity medications and the treatment of type 2 diabetes. Diabetes Technol. Ther., 1: 277-287.
CrossRefDirect Link - Grover, J.K., S. Yadav and V. Vats, 2002. Medicinal plants of Indian with anti-diabetic potential. J. Ethnopharmacol., 81: 81-100.
Direct Link - Han, L., W. Li, S. Narimatsu, L. Liu and H. Fu et al., 2007. Inhibitory effect of compounds isolated from fruit of Juglans mandshurica on pancreatic lipase. J. Nat. Med., 61: 184-186.
CrossRefDirect Link - Han, L.K., Y. Kimura and M. Kawashima, 2001. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int. J. Obesity, 25: 1459-1464.
PubMedDirect Link - Huerta, V., K. Mihalik, V. Maitin, S. HCrixell and D.A. Vattem, 2007. Effect of central/South American medicinal plants on energy harvesting ability of the mammalian gi tract. J. Med. Plants. Res., 1: 038-049.
Direct Link - Jang, D.S., G.Y. Lee, J. Kim, Y.M. Lee and J.M. Kim et al., 2008. A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta. Arch. Pharm. Res., 31: 666-670.
Direct Link - Joseph, B., M.A. Dar and V. Kumar, 2008. Bioefficacy of plant extracts to control Fusarium solani f. sp. melongenae incitant of brinjal wilt. Global J. Biotechnol. Biochem., 3: 56-59.
Direct Link - Kaur, G., H. Hamid, A. Ali, M.S. Alam and M. Athar, 2004. Antiinflammatory evaluation of alcoholic extract of galls of quercus infectoria. J. Ethnopharmacol, 90: 285-292.
PubMedDirect Link - Kumar, A.S., A. Mazumder and V.S. Saravanan, 2008. Antihyperlipidemic activity of camellia sinensis leaves in triton wr-1339 induced albino rats. Phcog. Mag., 4: 60-64.
Direct Link - Moreno, D.A., N. Ilic, A. Poulev and I. Raskin, 2006. Effects of arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Life Sci., 78: 2797-2803.
CrossRefDirect Link - Moreno, D.A., N. Ilic and A. Poulev, 2003. Inhibitory effects of grape seed extract on lipases. Nutr., 19: 876-879.
CrossRefPubMedDirect Link - Morikawa, T., Y. Xie, Y. Aso, M. Okamoto and C. Yamashita(et al)., 2009. Oleanane-type triterpene oligoglycosides with pancreatic lipase inhibitory activity from the pericarps of Sapindus rarak. Phytochemistry, 70: 1166-1172.
CrossRef - Moro, C.O. and G. Basile, 2000. Obesity and medicinal plants. Fitoterapia, 71: S73-S82.
PubMedDirect Link - Pin, K.Y., T.G. Chuah, A.A. Rashid, M.A. Rasadah and T.S.Y. Choong et al., 2006. Effect of the concentration of Quercus infectoria galls (Manjakani) extract on moisture content and quality of its freeze-dried product. Int. J. Eng. Technol., 3: 167-174.
Direct Link - Prakash, P. and N. Gupta, 2005. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J. Physiol. Pharmacol., 49: 125-131.
PubMedDirect Link - Rocha, J.M.S., M.H. Gil and F.A.P. Garcia, 1999. Optimisation of the enzymatic synthesis of n-octyl oleate with immobilized lipase in the absence of solvents. Chem. Technol. Biotechnol., 74: 607-612.
Direct Link - Ros, E., 2000. Intestinal absorption of triglyceride and cholesterol: Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis, 51: 357-379.
CrossRefPubMedDirect Link - Sebban-Kreuzer, C., L. Ayvazian and C. Juhel, 2003. Inhibitory effect of the pancreatic lipase c-terminal domain on intestinal lipolysis in rats fed a high-fat diet chronic study. Int. J. Obesity, 27: 319-325.
CrossRefDirect Link - Sharma, N., V.K. Sharma and S.Y. Seo, 2005. Screening of some medicinal plants for anti-lipase activity. J. Ethnopharmacol., 97: 453-456.
PubMedDirect Link - Tashiro, J., J. Kobayashi, K. Shirai, Y. Saito, H. Nakamura, Y. Morimoto and S. Yoshida, 1992. Trypsin treatment may impair the interfacial activation action of lipoprotein lipase. J. Biochem., 111: 509-514.
Direct Link - Won, S.R., S.K. Kim, Y.M. Kim, P.H. Lee, J.H. Ryu, J.W. Kim and H.I. Rhee, 2007. Licochalcone A: A lipase inhibitor from the roots of Glycyrrhiza uralensis. Food Res. Int., 40: 1046-1050.
CrossRefDirect Link - Xie, W., W. Wang, H. Su, D. Xing, G. Cai and L. Du, 2007. Hypolipidemic mechanisms of Ananas comosus L. leaves in mice: Different from fibrates but similar to statins. J. Pharmacol. Sci., 103: 267-274.
CrossRefDirect Link - Yamada, M. and T. Fujita, 2007. New procedure for the measurement of pancreatic lipase activity in human serum using a thioester substrate. Clinica. Chimica. Acta., 383: 85-90.
CrossRefDirect Link - Shihabi, Z.K. and C. Bishop, 1971. Simplified turbidimetric assay for lipase activity. Clin. chem., 17: 1150-1153.
PubMedDirect Link - Zhao, H.L. and Y.S. Kim, 2004. Determination of the kinetic properties of platycodin d for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay. Arch. Pharm. Res., 27: 1048-1052.
CrossRefDirect Link